What is the purpose of this study and why participate?
SARS-CoV-2 is the virus responsible for COVID-19 disease. Recent roll out of licensed vaccines is a positive step towards fighting COVID-19. However, we don’t know how long protection after COVID-19 infection lasts and why some people can get infected a second time.
The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.
Are you a parent or guardian of a child aged 0-5 years?
You may be interested in taking part in a study about vaccine attitudes.
This study is run by Oxford Vaccine Group, part of the University of Oxford.
What is the study about?
We will be holding focus groups (discussions) with small groups of parents of children aged 0-5 years.